Expressing support for the designation of May as Ehlers-Danlos Syndrome Awareness Month to increase the knowledge of this little-known, potentially fatal, genetic disease.

This resolution supports the designation of Ehlers-Danlos Syndrome Awareness Month. This syndrome is a group of inherited disorders that affect collagen in skin, joints, and other connective tissue.

Bill 118 HRES 419, also known as the Ehlers-Danlos Syndrome Awareness Month Resolution, is a piece of legislation that aims to raise awareness about Ehlers-Danlos Syndrome (EDS) by designating the month of May as EDS Awareness Month. EDS is a genetic disorder that affects the body's connective tissues, leading to symptoms such as joint hypermobility, skin fragility, and chronic pain.

The resolution highlights the importance of increasing knowledge about EDS, as it is a little-known and potentially fatal disease. By designating May as EDS Awareness Month, the hope is to educate the public about the impact of EDS on individuals and families, as well as to promote research and support for those affected by the disorder.

Overall, Bill 118 HRES 419 seeks to bring attention to EDS and the challenges faced by those living with the condition. It emphasizes the need for increased awareness, research, and support for individuals with EDS, in order to improve their quality of life and ultimately find a cure for this genetic disease.